Novartis CAR-T cancer therapy wins expert support for FDA approval

(By Adam Feuerstein and Damian Garde for STAT)

Novartis’ groundbreaking CAR-T cancer therapy is one big step closer to reaching patients. Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.